Twitter

Archive for March 16th, 2012


Prostate Cancer Run/Walk – CTV Edmonton (March 9, 2012)

Some poignant images are part of a photo exhibit featuring men who’ve been diagnosed with prostate cancer. Meet prostate cancer survivor Mike Williams, and photographer Amber Bracken who captured his image. Prostate Cancer Run/Walk: www.prostatecancer.ca

Read More...

Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia

Condition :   Acute Lymphoblastic Leukemia Intervention :   Sponsor :   Seoul National University Hospital Active, not recruiting – verified March 2012

Read More...

Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis

Condition :   Primary Sclerosing Cholangitis Intervention :   Sponsor :   Tischendorf, Jens, M.D. Recruiting – verified March 2012

Read More...

Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma

Condition :   Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) Intervention :   Drug: Lenalidomide Sponsor :   University Hospital, Bordeaux Not yet recruiting – verified March 2012

Read More...

The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).

Conditions :   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia Interventions :   Drug: Azacitidine;   Drug: azacitidine + lenalidomide Sponsor :   Nordic MDS Group Recruiting – verified March 2012

Read More...

Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma

Conditions :   Lymphoma, Non-Hodgkin;   Hodgkin Disease Interventions :   Drug: Abraxane;   Drug: Abraxane;   Drug: Abraxane;   Drug: Abraxane Sponsor :   Washington University School of Medicine Not yet recruiting – verified March 2012

Read More...

A Phase 3 Study of the Efficacy and Safety of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Condition :   Chronic Lymphocytic Leukemia Interventions :   Drug: lenalidomide;   Drug: Placebo Sponsors :   German CLL Study Group;   Celgene Corporation Not yet recruiting – verified March 2012

Read More...

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Conditions :   Cutaneous Lymphoma;   Other Skin Disorders;   Mycosis Fungoides Intervention :   Sponsor :   Stanford University Not yet recruiting – verified March 2012

Read More...

Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

Condition :   Stage IV Lung Cancer Interventions :   Drug: Gefitinib;   Drug: Fulvestrant;   Drug: Erlotinib Sponsor :   Intergroupe Francophone de Cancerologie Thoracique Not yet recruiting – verified March 2012

Read More...

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas

Conditions :   Pituitary Adenoma;   Pituitary Tumor Intervention :   Sponsors :   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS) Recruiting – verified March 2012

Read More...